IC
LYEL icon

IEQ Capital’s Lyell Immunopharma LYEL Stock Holding History

IEQ Capital’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-820
Closed -$8.82K – 1922
2025
Q1 		$8.82K Buy
+820
New +$10K ﹤0.01% 1601
2024
Q1 		– Sell
-4,108
Closed -$159K – 993
2023
Q4 		$159K Hold
4,108
– – ﹤0.01% 856
2023
Q3 		$121K Buy
+4,108
New +$195K ﹤0.01% 877

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

IEQ Capital's LYEL Position: Q2 2025 in Review

IEQ Capital sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 820 shares — an estimated $8.82K sold.

IEQ Capital first reported a position in LYEL in Q3 2023 and held it in 3 quarters. The position peaked at $159K in Q4 2023. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • IEQ Capital reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • IEQ Capital sold 820 Lyell Immunopharma shares in Q2 2025, an estimated $8.82K.
  • IEQ Capital first reported a position in Lyell Immunopharma in Q3 2023 and held it in 3 quarters.
  • IEQ Capital's Lyell Immunopharma position peaked at $159K in Q4 2023.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on IEQ Capital's 13F filing for Q2 2025, filed 14 Aug 2025.